XGD Probe PR-XGD
by Otodynamics
Part of a family of 6 devices: see the family page
Ref PR-XGDModel PROBE
XGD Probe PR-XGD is a device classified as Class IIa in the EU and Class II in the US made by Otodynamics, registered in EUDAMED on 3 Nov 2026 (Basic UDI-DI 506039617PROBEBU) and listed in FDA GUDID since 1 Apr 2023 (UDI-DI 05060396172199), active as of 7 Nov 2026.
Active
CE MDR
Valid until
No date given
FDA recalls
Not checked
Documents
None linked in EUDAMED
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/MDR EUDAMED | Number506039617PROBEBU 05060396172199 | Date3 Nov 2026 | StatusActive |
| United States | GUDID listing GUDID | Number05060396172199 | Date1 Apr 2023 | StatusListed |
Official records
- EUDAMED public site 506039617PROBEBU
- AccessGUDID record 05060396172199
Across registries
- EUDAMED Basic UDI-DI 506039617PROBEBU registered 3 Nov 2026 Active
- FDA GUDID UDI-DI 05060396172199 listed 1 Apr 2023 Listed
Timeline
- Listed FDA GUDID 05060396172199
- Registered EUDAMED 506039617PROBEBU
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- Trade name
- XGD Ear Probe EUDAMEDXGD Probe GUDID
- Generic name
- Evoked-potential audiometer
- Device name
- Otodynamics Ear Probes
- Model / reference
- PR-XGD, PROBE
- Primary DI / UDI-DI
- 05060396172199
- Basic UDI-DI
- 506039617PROBEBU
- Direct marketing DI
- 05060396172199
- FDA product code
- EWO, GWJ
- EMDN code
- Z12149001 Otoacoustic emissions equipment
- GMDN term
- Evoked-potential audiometer
- Device class
- Class IIa EUDAMEDClass II GUDID
- Regulation number
- 874.1050, 882.1900
- EU registration type
- Standard device
- EU market of registration
- Austria
- GUDID distribution status
- In Commercial Distribution
- MRI safety
- MR Unsafe
Truth per registry
| Field | EUDAMED | GUDID |
|---|---|---|
| Device class | Class IIa | Class II |
Similar devices in this category
Other devices filed under OTOACOUSTIC EMISSIONS EQUIPMENT.